Furthermore, we also found the up-regulation of α- and β-synuclein (P37377 and Q63754, respectively) that have been suggested as components of Lewis bodies and cerebrospinal fluid in Alzheimer’s and Parkinson’s diseases [78,79]. This evidence concerns the gene SNCB and Parkinson disease.